Mananding, Jimmy M.

HRN: 16-97-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFTRIAXONE 1G (VIAL)
03/25/2024
03/31/2024
IV
2gm
OD
T/C Lung Abscess
Waiting Final Action 
03/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2024
03/31/2024
IV
500mg
Q6
T/C Lung Abscess Vs Empyema
Waiting Final Action 
03/27/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/27/2024
04/10/2024
IV
4.5g
Q8
CAP-HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: